BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28157155)

  • 1. Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.
    Akinwumi BC; Raj P; Lee DI; Acosta C; Yu L; Thomas SM; Nagabhushanam K; Majeed M; Davies NM; Netticadan T; Anderson HD
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral and Cerebral Resistance Arteries in the Spontaneously Hypertensive Heart Failure Rat: Effects of Stilbenoid Polyphenols.
    Lee DI; Acosta C; Anderson CM; Anderson HD
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway.
    Thandapilly SJ; Louis XL; Yang T; Stringer DM; Yu L; Zhang S; Wigle J; Kardami E; Zahradka P; Taylor C; Anderson HD; Netticadan T
    Eur J Pharmacol; 2011 Oct; 668(1-2):217-24. PubMed ID: 21756902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protective Role of the Long Pentraxin PTX3 in Spontaneously Hypertensive Rats with Heart Failure.
    Chen W; Zhuang YS; Yang CX; Fang ZC; Liu BY; Zheng X; Liao YY
    Cardiovasc Toxicol; 2021 Oct; 21(10):808-819. PubMed ID: 34173191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
    Dolinsky VW; Chakrabarti S; Pereira TJ; Oka T; Levasseur J; Beker D; Zordoky BN; Morton JS; Nagendran J; Lopaschuk GD; Davidge ST; Dyck JR
    Biochim Biophys Acta; 2013 Oct; 1832(10):1723-33. PubMed ID: 23707558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.
    Thandapilly SJ; Wojciechowski P; Behbahani J; Louis XL; Yu L; Juric D; Kopilas MA; Anderson HD; Netticadan T
    Am J Hypertens; 2010 Feb; 23(2):192-6. PubMed ID: 19942861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
    Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
    Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
    He T; Chen L; Chen Y; Han Y; Yang WQ; Jin MW
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure.
    Muñoz-Pacheco P; Ortega-Hernández A; Caro-Vadillo A; Casanueva-Eliceiry S; Aragoncillo P; Egido J; Fernández-Cruz A; Gómez-Garre D
    J Hypertens; 2013 Nov; 31(11):2309-18; discussion 2319. PubMed ID: 24077250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cacao Bean Polyphenols Inhibit Cardiac Hypertrophy and Systolic Dysfunction in Pressure Overload-induced Heart Failure Model Mice.
    Sari N; Katanasaka Y; Honda H; Miyazaki Y; Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Wada H; Hasegawa K; Morimoto T
    Planta Med; 2020 Nov; 86(17):1304-1312. PubMed ID: 32645737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis.
    Yin K; Zhao L; Feng D; Ma W; Liu Y; Wang Y; Liang J; Yang F; Bi C; Chen H; Li X; Lu Y; Cai B
    Cell Physiol Biochem; 2015; 35(6):2451-62. PubMed ID: 25967874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
    Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
    Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
    Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoprotein abundance changes in hypertensive cardiac remodeling.
    Kotlo K; Johnson KR; Grillon JM; Geenen DL; deTombe P; Danziger RS
    J Proteomics; 2012 Dec; 77():1-13. PubMed ID: 22659219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
    Gu XS; Wang ZB; Ye Z; Lei JP; Li L; Su DF; Zheng X
    Genet Mol Res; 2014 Jan; 13(1):323-35. PubMed ID: 24535859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
    Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
    Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.